MARKET

VIVS

VIVS

VivoSim Labs Inc
NASDAQ
2.290
+0.090
+4.09%
Closed 16:34 12/04 EST
OPEN
2.160
PREV CLOSE
2.200
HIGH
2.401
LOW
2.160
VOLUME
117.49K
TURNOVER
31.95K
52 WEEK HIGH
21.96
52 WEEK LOW
1.410
MARKET CAP
5.97M
P/E (TTM)
1.199
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VIVS last week (1124-1128)?
Weekly Report · 4d ago
VivoSim Labs Inc. Files Initial Statement of Beneficial Ownership for Chief Scientific Officer Amar Akhtar Sethi
Reuters · 11/26 23:08
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 11/25 12:05
Weekly Report: what happened at VIVS last week (1117-1121)?
Weekly Report · 11/24 09:15
Weekly Report: what happened at VIVS last week (1110-1114)?
Weekly Report · 11/17 09:15
Weekly Report: what happened at VIVS last week (1103-1107)?
Weekly Report · 11/10 09:15
VivoSim Labs Inc. Announces Date for Upcoming Annual Stockholders Meeting
Reuters · 11/03 21:07
Weekly Report: what happened at VIVS last week (1027-1031)?
Weekly Report · 11/03 09:15
More
About VIVS
VivoSim Labs, Inc. is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The Company offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. It uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The Company's 3D human tissue platform is multifaceted. The Company has expertise in 3D organoids, such as spheroids, and has made advances in proprietary cell culture techniques including ratios, components and conditions.

Webull offers VivoSim Labs Inc stock information, including NASDAQ: VIVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIVS stock methods without spending real money on the virtual paper trading platform.